This study investigated whether microvessel density (MVD) and mast cell infiltration are related to prognosis in non-small cell lung carcinoma (NSCLC), and examined the possible role of mast cells in NSCLC angiogenesis. MVD and mast cell infiltration were analysed retrospectively in tumour specimens from 50 patients with primary NSCLC. Immunohistochemistry with monoclonal antibody anti-CD34 was used to delineate the microvessels and routine Giemsa blue staining was used to assess the number of mast cells. Significant correlations were found between MVD and mast cell infiltration and between MVD and both lymph node metastasis and tumour, node, metastases (TNM) stage. No significant correlations were found with respect to survival for MVD or mast cell infiltration. Multivariate analysis showed that TNM stage and tumour size were independent predictors of survival, suggesting that the TNM staging system remains the most important tool for the estimation of prognosis in NSCLC patients.
SinghalSVachaniAOzerkisD Antin: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res2005; 11: 3974–3986.
2.
HanHSilvermanJFSantucciTS: Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol2001; 8: 72–79.
3.
WeidnerNSempleJPWelchWR: Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med1991; 324: 1–8.
4.
WeidnerNCarrollPRFlaxJ: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol1993; 143: 401–409.
5.
SrivastavaALaidlerPDaviesRP: The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol1998; 133: 419–423.
WilliamsJKCarlsonGWCohenC: Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg1994; 168: 373–380.
8.
BochnerBHCoteRJWeidnerN: Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis. J Natl Cancer Inst1995; 87: 1603–1612.
9.
MaedaKChungYSTakatsukaS: Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer1995; 72: 319–323.
10.
AcikalinMFOnerUTopcuI: Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis2005; 37: 162–169.
11.
MacchiariniPFontaniniGHardinMJ: Relation of neovascularisation to metastasis of non-small cell lung cancer. Lancet1992; 340: 145–146.
12.
FontaniniGVignatiSBiginiD: Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development. Int J Cancer1996; 67: 615–619.
13.
YamazakiKAbeSTakekawaH: Tumor angiogenesis in human lung adenocarcinoma. Cancer1994; 74: 2245–2250.
14.
MatsuyamaKChibaYSasakiM: Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg1998; 65: 1405–1409.
15.
ShibusaTShijuboNAbeS: Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res1998; 4: 1483–1487.
16.
OhtaYTomitaYOdaM: Tumor angiogenesis and recurrence in stage I non-small lung cancer. Ann Thorac Surg1999; 68: 1034–1038.
17.
DuarteIGBufkinBLPenningtonMF: Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg1998; 115: 652–658.
TanakaFOtakeYYanagiharaK: Evaluation of angiogenesis in non-small cell lung cancer: Comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res2001; 7: 3410–3415.
20.
ChandrachudLMPendletonNChisholmDM: Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer1997; 76: 1367–1375.
21.
BrattstromDWesterKBergqvistM: HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer. Acta Oncol2004; 43: 80–86.
22.
TsoliEZacharatosPPlakidaD Dasiou: Growth index is independent of microvessel density in non-small-cell lung carcinomas. Hum Pathol2002; 33: 812–818.
23.
DazziCCarielloAMaioliP: Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer. Lung Cancer1999; 24: 81–88.
24.
DecaussinMSarteletHRobertC: Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival. J Pathol1999; 188: 369–377.
25.
TharpMD: The interaction between mast cells and endothelial cells. J Invest Dermatol1989; 93 (suppl): 107S–112S.
26.
HartveitFThoresenSTangenM: Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis1984; 4: 146–155.
27.
YanoHKinutaMTateishiH: Mast cell infiltration around gastric cancer correlates with tumor angiogenesis and metastasis. Gastric Cancer1999; 2: 26–32.
28.
ElpekGOGelenTAksoyNH: The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol2001; 54: 940–944.
29.
IamaroonAPongsiriwetSJittidecharaksS: Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med2003; 32: 195–199.
30.
SawatsubashiMYamadaTFukushimaN: Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch2000; 436: 243–248.
31.
RibattiDEnnasMGVaccaA: Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest2003; 33: 420–425.
32.
AaltomaaSLipponenPPapinahoS: Mast cells in breast cancer. Anticancer Res1993; 13: 785–788.
33.
LachterJSteinMLichtigC: Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum1995; 38: 290–293.
34.
TatarogluCKargiAOzkalS: Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung Cancer2004; 43: 47–54.
35.
WelshTJGreenRHRichardsonD: Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small cell lung cancer. J Clin Oncol2005; 23: 8959–8967.
36.
IbarakiTMuramatsuMTakaiS: The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg2005; 28: 617–621.
37.
TomitaMMatsuzakiYOnitsukaT: Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer1999; 26: 103–108.
38.
TakanamiITakeuchiKNarukeM: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer2000; 88: 2686–2692.
39.
TomitaMMatsuzakiYOnitsukaT: Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg2000; 69: 1686–1690.
